Detalhe da pesquisa
1.
Assessment of hydro-saline retention in bullous pemphigoid patients treated with super-potent topical corticosteroids.
Ann Dermatol Venereol
; 150(1): 35-38, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36257854
2.
Impact of the first wave of the COVID-19 pandemic on the treatment of psoriasis with systemic therapies in France: Results from the PSOBIOTEQ cohort.
Ann Dermatol Venereol
; 150(2): 101-108, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36914553
3.
Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open-label feasibility trial.
Br J Dermatol
; 186(3): 429-439, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34608631
4.
Switches between biologics in patients with moderate-to-severe psoriasis: results from the French cohort PSOBIOTEQ.
J Eur Acad Dermatol Venereol
; 36(11): 2101-2112, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35793473
5.
Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large, prospective cohort study.
J Eur Acad Dermatol Venereol
; 36(11): 2181-2189, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35796163
6.
International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg-1 per day starting dose of oral corticosteroids to treat bullous pemphigoid.
Br J Dermatol
; 185(6): 1232-1239, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34173243
7.
Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study.
Br J Dermatol
; 185(4): 745-755, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33942286
8.
International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoid.
Br J Dermatol
; 184(6): 1106-1112, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33067805
9.
Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry.
Br J Dermatol
; 184(6): 1059-1067, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33131055
10.
Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus.
Br J Dermatol
; 185(3): 616-626, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33657677
11.
Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate-to-severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI-PSO study.
J Eur Acad Dermatol Venereol
; 35(3): 677-684, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32815591
12.
Out-of-pocket expenditures in France to manage psoriasis in adult patients: results from an observational, cross-sectional, non-comparative, multicentre study.
J Eur Acad Dermatol Venereol
; 35(4): 912-918, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33073410
13.
European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I.
J Eur Acad Dermatol Venereol
; 35(9): 1750-1764, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34245180
14.
European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II.
J Eur Acad Dermatol Venereol
; 35(10): 1926-1948, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34309078
15.
Prevalence of comorbidities in atopic dermatitis and psoriasis in the French population.
Ann Dermatol Venereol
; 148(1): 28-33, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33500190
16.
Comparison of real costs in the French healthcare system in newly diagnosed patients with pemphigus for first-line treatment with rituximab vs. standard corticosteroid regimen: data from a national multicentre trial.
Br J Dermatol
; 183(1): 121-127, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31657454
17.
Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.
Br J Dermatol
; 182(5): 1111-1119, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31487383
18.
Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQ.
J Eur Acad Dermatol Venereol
; 34(2): 293-300, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31419355
19.
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV).
J Eur Acad Dermatol Venereol
; 34(9): 1900-1913, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32830877
20.
Automatic depletion with Spectra Optia allows a safe 16% reduction of red blood cell pack consumption in exchanged sickle cell anemia patients.
Transfusion
; 59(5): 1692-1697, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30747440